{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:48:31Z","timestamp":1791280111281,"version":"4.1.0"},"reference-count":24,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3318,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Neurol."],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1002\/ana.20935","type":"journal-article","created":{"date-parts":[[2006,7,21]],"date-time":"2006-07-21T23:40:09Z","timestamp":1153525209000},"page":"264-268","source":"Crossref","is-referenced-by-count":121,"title":["Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys"],"prefix":"10.1002","volume":"60","author":[{"given":"Jeffrey H.","family":"Kordower","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Kanaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangasamy","family":"Suresh Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"James","family":"Stansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Terpstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryl E.","family":"Sortwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Steece-Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1002\/ana.20935-BIB1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","article-title":"Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease","volume":"56","author":"McNaught","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1002\/ana.20935-BIB2","first-page":"15","volume-title":"Parkinson's disease and movement disorders","author":"Elble","year":"1998"},{"key":"10.1002\/ana.20935-BIB3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"pt 5","key":"10.1002\/ana.20935-BIB4","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1002\/ana.20935-BIB5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0892-0362(03)00091-6","article-title":"Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats","volume":"25","author":"Koprich","year":"2003","journal-title":"Neurotoxicol Teratol"},{"key":"10.1002\/ana.20935-BIB6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/cne.20828","article-title":"Nurr1 in Parkinson's disease and related disorders","volume":"494","author":"Chu","year":"2006","journal-title":"J Comp Neurol"},{"key":"10.1002\/ana.20935-BIB7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neurobiolaging.2005.04.002","article-title":"RET expression does not change with age in the substantia nigra pars compacta of rhesus monkeys","volume":"27","author":"Dass","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1002\/ana.20935-BIB8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainres.2005.10.078","article-title":"Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease","volume":"1068","author":"Kanaan","year":"2006","journal-title":"Brain Res"},{"key":"10.1002\/ana.20935-BIB9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.20936","article-title":"The proteasome inhibitor-induced model of Parkinson's disease","volume":"60","author":"McNaught","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1002\/ana.20935-BIB10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.20932","article-title":"Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats","volume":"60","author":"Zeng","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1002\/ana.20935-BIB11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.20934","article-title":"Proteosomal inhibition causes loss of nigral tyrosine hydroxylase neurons","volume":"60","author":"Schapira","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1002\/ana.20935-BIB12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.20938","article-title":"Lack of nigrostriatal pathology in a rat model of proteosome inhibition","volume":"60","author":"Manning-Bog\u0306","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1002\/ana.20935-BIB13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.20937","article-title":"Proteasome inhibition and Parkinson's disease modeling","volume":"60","author":"Bov\u00e9","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1002\/ana.20935-BIB14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ana.20939","article-title":"The proteosomal inhibition model of Parkinson's disease: \u201cboon or bust\u201d?","volume":"60","author":"Lang","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1002\/ana.20935-BIB15","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1471-4159.2005.03124.x","article-title":"Dopaminergic neurons in rat ventral midbrain cultures undergo selective apoptosis and form inclusions, but do not up-regulate iHSP70, following proteasomal inhibition","volume":"93","author":"Rideout","year":"2005","journal-title":"J Neurochem"},{"key":"10.1002\/ana.20935-BIB16","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.febslet.2004.12.091","article-title":"L-dopa and dopamine enhance the formation of aggregates under proteasome inhibition in PC12 cells","volume":"579","author":"Yoshimoto","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1002\/ana.20935-BIB17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00702-004-0167-2","article-title":"Inhibition of proteasome activity sensitizes dopamine neurons to protein alterations and oxidative stress","volume":"111","author":"Mytilineou","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1002\/ana.20935-BIB18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neulet.2003.10.048","article-title":"p53-mediated mitochondrial dysfunction by proteasome inhibition in dopaminergic SH-SY5Y cells","volume":"354","author":"Nakaso","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1002\/ana.20935-BIB19","doi-asserted-by":"crossref","first-page":"10710","DOI":"10.1074\/jbc.M308434200","article-title":"Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions","volume":"279","author":"Sawada","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1002\/ana.20935-BIB20","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1523\/JNEUROSCI.23-26-08955.2003","article-title":"Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition","volume":"23","author":"Fornai","year":"2003","journal-title":"J Neurosci"},{"key":"10.1002\/ana.20935-BIB21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0006-8993(02)04030-1","article-title":"Effect of proteasome inhibitor on cultured mesencephalic dopaminergic neurons","volume":"964","author":"Kikuchi","year":"2003","journal-title":"Brain Res"},{"key":"10.1002\/ana.20935-BIB22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1471-4159.2002.00821.x","article-title":"Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures","volume":"81","author":"McNaught","year":"2002","journal-title":"J Neurochem"},{"key":"10.1002\/ana.20935-BIB23","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1091\/mbc.e03-02-0078","article-title":"Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin","volume":"14","author":"Ardley","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1002\/ana.20935-BIB24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2005.01.024","article-title":"Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition","volume":"380","author":"Miwa","year":"2005","journal-title":"Neurosci Lett"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.20935","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/ana.20935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T14:18:52Z","timestamp":1625149132000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.20935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"URL":"https:\/\/doi.org\/10.1002\/ana.20935","relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}